Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwNHL 2017 | Clinical trials, pathologies and developments in personalized medicine

Francesco d'Amore, Laurence de Leval, Philippe Gaulard and Richard Delarue • 18 Sep 2017
iwNHL 2017
Non-Hodgkin Lymphoma

Philippe Gaulard, MD, PhD, from the Henri-Mondor Hospital, Paris, France, Francesco D’Amore, MD, PhD, from the Aarhus University, Aarhus, Denmark, Richard Delarue, MD, from the Necker-Enfants Malades Hospital, Paris, France, discuss topics such as recent developments in molecular pathology, results of recent clinical trials, and novel opportunities in personalized medicines in lymphoma at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada.

More from Francesco d'Amore

Managing T-cell lymphomas in light of the updated WHO classification
7:22
Managing T-cell lymphomas in light of the updated WHO classification
Francesco d'Amore • 27 Sep 2019
iwNHL 2017: T-cell lymphomas, Hodgkin's lymphoma, immunotherapy and epigenetics
iwNHL 2017: T-cell lymphomas, Hodgkin's lymphoma, immunotherapy and epigenetics
Francesco d'Amore et al. • 8 Sep 2017
Update of peripheral T-cell lymphoma treatment
6:49
Update of peripheral T-cell lymphoma treatment
Elaine Jaffe et al. • 5 Sep 2014
iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma
4:37
iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma
Francesco d'Amore et al. • 3 Oct 2015

More from Laurence de Leval

The need to refine the definition of nodal-based lymphomas
1:18
The need to refine the definition of nodal-based lymphomas
Laurence de Leval • 27 Sep 2025
Differences between the WHO and ICC definitions of T-cell malignancies
1:52
Differences between the WHO and ICC definitions of T-cell malignancies
Laurence de Leval • 27 Sep 2025
The integration of evolving molecular insights in diagnostic algorithms for lymphoid malignancies
2:38
The integration of evolving molecular insights in diagnostic algorithms for lymphoid malignancies
Laurence de Leval • 27 Sep 2025
Classifying lymphoid malignancies: including AI-based pathology, multimodal data, and liquid biopsy
2:03
Classifying lymphoid malignancies: including AI-based pathology, multimodal data, and liquid biopsy
Laurence de Leval • 27 Sep 2025

Related Videos

Exploring CAR-T and bispecifics in CLL: novel approaches beyond BTK and BCL2 inhibitors
2:30
Exploring CAR-T and bispecifics in CLL: novel approaches beyond BTK and BCL2 inhibitors
Alexey Danilov • 16 Oct 2026
Genomic and immune signatures of ibrutinib response & resistance in Waldenström's macroglobulinemia
2:39
Genomic and immune signatures of ibrutinib response & resistance in Waldenström's macroglobulinemia
Tina Bagratuni • 23 Sep 2026
Unresolved questions in T-cell lymphoma: individualized therapy and access to new technologies
2:13
Unresolved questions in T-cell lymphoma: individualized therapy and access to new technologies
Mary Jo Lechowicz • 11 Sep 2026
Key advances in FL management expected to change practice over the next five years
1:26
Key advances in FL management expected to change practice over the next five years
Kim Linton • 11 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals